Advertisement

Lungenparenchymerkrankungen

  • U. Costabel
  • U. Greinert
  • A. Günther
  • F. Grimminger
  • C. Lange
  • J. Lohmeyer
  • J. Müller-Quernheim
  • A. Prasse
  • E. W. Russi
  • W. Seeger
  • B. Temmesfeld-Wollbrück
  • H. D. Walmrath
  • P. Zabel
Chapter
  • 3.4k Downloads

Auszug

Das Lungenemphysem ist pathologisch-anatomisch definiert. Man versteht darunter eine irreversible abnorme Erweiterung der lufthaltigen Räume distal der Bronchioli terminales, die mit einer Destruktion der Alveolarsepten einhergeht. Neben der chronischen Bronchitis und der Bronchiolitis ist das Lungenemphysem eine der morphologischen Komponenten der chronisch-obstruktiven Lungenkrankheit (COPD). Bei fortgeschrittenen Formen der COPD besteht mit Regelmäßiigkeit ein erhebliches Lungenemphysem.

Literatur

  1. Anthonisen NR, Connett JE, Murray RP (2002) Smoking and lung function of lung health study participants after 11 years. Am J Respir Crit Care Med 166:675–679PubMedGoogle Scholar
  2. Biernacki W, Gould GA, Whyte K, Flenley DC (1989) Pulmonary hemodynamics, gas exchange, and the severity of emphysema as assessed by quantitative ct scan in chronic bronchitis and emphysema. Am Rev Respir Dis 139:1509–1515PubMedGoogle Scholar
  3. Bloch KE, Li Y, Zhang J, Bingisser R, Kaplan V, Russi EW (1997) Effect of surgical lung volume reduction on breathing patterns in severe pulmonary emphysema. Am J Respit Crit Care Med 156:553–560Google Scholar
  4. Brantigan OC, Mueller EA, Kress MB (1957) A surgical approach to pulmonary emphysema. Am Surgeon 23:789–804PubMedGoogle Scholar
  5. Carrell RW, Lomas DA (2002) Mechanisms of disease: alpha1-antitrypsin deficiency — a model for conformational diseases. New Engl J Med 346:45–53PubMedGoogle Scholar
  6. Cassivi SD, Meyers BF, Battafarano RJ et al. (2002) Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 74:1663–166PubMedGoogle Scholar
  7. Cooper JD, Trulock EP, Triantafillou AN et al. (1995) Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 109:106–119PubMedGoogle Scholar
  8. Cooper JD, Patterson GA, Trulock EP, Washington University Lung Transplant Group (1994) Results of single and bilateral lung transplantation in 131 consecutive recipients. J Thorac Cardiovasc Surg 107:460–471PubMedGoogle Scholar
  9. Gaensler EA, Carter MG (1950) Ventilation measurements in pulmonary emphysema treated with pneumoperitoneum. J Lab & Clin Med 35:945–959Google Scholar
  10. GOLD (2006) Global Strategy for Diagnosis, Management, and Prevention of COPD (GOLD guidelines). November 2006; http://www.goldcopd.com/Google Scholar
  11. Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH (1994) Randomised controlled trial of respiratory rehabilitation. Lancet 344,19:1394–1397PubMedGoogle Scholar
  12. Imfeld St, Bloch KE, Weder W, Russi EW. (2006) The BODE index after lung volume reduction surgery correlates with survival. Chest 129:873–878PubMedGoogle Scholar
  13. Madani A, Zanen J, de Maertelaer V, Gevenois PA (2006) Pulmonary emphysema: objective quantification at multi-detector row CT — comparison with macroscopic and microscopic morphometry. Radiology 238:1036–1093PubMedGoogle Scholar
  14. Massaro GD, Massaro D (1997) Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nature Medicine 3:675–677PubMedGoogle Scholar
  15. Maxfield RA (2004) New and emerging minimally invasive techniques for lung volume reduction. Chest 125:777–783PubMedGoogle Scholar
  16. National Emphysema Treatment Trial Research Group (2001) Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 345:1075–1083Google Scholar
  17. National Emphysema Treatment Trial Research Group (2003) A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348:2059–2073Google Scholar
  18. O’Donnell DE, Revill SM, Webb KA (2001) Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:770–777PubMedGoogle Scholar
  19. Russi EW, Stammberger U, Weder W (1997) Lung volume reduction surgery for emphysema. Eur Respir J 19:208–218Google Scholar
  20. Sciurba FC, Rogers RM, Keenan RJ et al. (1996) Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 334:1095–1099PubMedGoogle Scholar
  21. Teschler H, Stamatis G, El-Raouf Farhat AA, Meyer FJ, Costabel U, Konietzko N (1996) Effect of surgical lung volume reduction on respiratory muscle function in pulmonary emphysema. Eur Respir J 9:1779–1784PubMedGoogle Scholar
  22. Thurnheer R, Bingisser R, Stammberger U, Muntwyler J, Zollinger A, Bloch KE, Weder W, Russi EW (1998) Effect of lung volume reduction surgery on pulmonary hemodynamics in severe pulmonary emphysema. Eur J Cardiothorac Surg 13:253–258PubMedGoogle Scholar
  23. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI (2006) Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult lung and heart-lung transplantation report 2006. J Heart Lung Transplant 25:880–892PubMedGoogle Scholar
  24. Tutic M, Lardinois, Imfeld S, Korom S, Boehler A, Speich R, Bloch KE, Russi EW, Weder W (2006) Lung volume reduction surgery as an alternative or bridging procedure to lung transplantation. Ann Thoracic Surg 82:208–213Google Scholar
  25. Weder W, Thurnheer R, Stammberger U, Bürge M, Russi EW, Bloch KE (1997) Radiological emphysema morphology is associated with outcome after surgical lung volume reduction. Ann Thorac Surg 64:313–320PubMedGoogle Scholar
  26. Wewers MD, Casolaro MA, Sellers SE, Swayze SC, McPhaul KM, Wittes JT and Crystal RG (1987) Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med 316:1055–1062PubMedGoogle Scholar

Literatur

  1. Allen GS, Coates NE (1996) Pulmonary contusion: a collective review. Am Surg 62:895–900PubMedGoogle Scholar
  2. Cohn SM (1997) Pulmonary contusion: review of the clinical entity. J Trauma 42:973–78.PubMedGoogle Scholar
  3. Klein Y, Cohn SM, Proctor KG (2002) Lung contusion: pathophysiology and management. Curr Opin Anaesthesiol 15:65–68PubMedGoogle Scholar

Literatur

  1. Boyd AD, Glassman LR (1997) Trauma to the lung. Chest Surg Clin N Am 7:263–83PubMedGoogle Scholar
  2. Stahel PF, Schneider P, Buhr HJ, Kruschewski M (2005) Die Notfallversorgung des Thoraxtrauma. Der Orthopäde 34:865–79PubMedGoogle Scholar

Literatur

  1. Kollef MH, Schuster DP (1995) The acute respiratory distress syndrome. NEJM 332:27–37PubMedGoogle Scholar
  2. Repine JE (1992) Scientific perspective on adult respiratory distress syndrome. Lancet 339:466–8PubMedGoogle Scholar
  3. Macnaughton PD, Evans TW (1992) Management of adult respiratory distress syndrome. Lancet 339:469–72PubMedGoogle Scholar
  4. Bernard GR, Artigas A, Brigham KL et al. (1994) Report of the american-european consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Int Care Med 20:225–32Google Scholar
  5. Artigas A, Bernard GR, Carlet J et al. (1998) The american-european consensus conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Int Care Med 24:378–98Google Scholar
  6. Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349PubMedGoogle Scholar

Literatur

  1. ATS, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Resp Crit Care 171:388–416Google Scholar
  2. Bauer TT, Ewig S, Marre R et al.; The CAPNETZ Study Group (2006) CRB-65 predicts death from community-acquired pneumonia. J Intern Med 260: 93–101PubMedGoogle Scholar
  3. Davies SF, Sarosi GA (1994) Infectious diseases of the lung/fungal infections. In: Murray JF, Nadel JA (ed) Textbook of respiratory medicine, 2nd edn. Saunders, Philadelphia, pp 1161–1200Google Scholar
  4. Fanta CH, Pennington JE. (1989) Pneumonia in the immunocompromised host. In: Pennington JE (ed) Respiratory infections: diagnosis and management, 2nd edn. Raven, New York, pp 221–240Google Scholar
  5. Feldmann C, Ross S, Mahomed AG, Omar J, Smith C (1995) The aetiology of severe community-acquired pneumonia and its impact of initial, empiric, antimicrobial chemotherapy. Respir Med 89:187–192Google Scholar
  6. Fine MJ, Auble TE, Yeale DM et al. (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250PubMedGoogle Scholar
  7. Finegold SM (1989) Aspiration pneumonia, lung abscess and empyema. In: Pennington JE (ed) Respiratory infections: diagnosis and management, 2nd edn. Raven, New York, pp 264–275Google Scholar
  8. Flückiger U, Battegay M, Laifer G (2007) Diagnostik bei ambulant erworbener Pneumonie. Internist 48:468–475PubMedGoogle Scholar
  9. Fraser DW, RF Tsai, Orenstein W (1997) Legionaires disease: description of an epidemic of pneumonia. N Engl J Med 297: 1189–1197Google Scholar
  10. Fraser RG, Paré JA, Paré PD, Fraser RS, Genereux GP (eds) (1989) Infectious diseases of the lungs, 3rd edn. Saunders, PhiladelphiaGoogle Scholar
  11. Gerberding JL, Sande MA (1994) Infectious diseases of the lungs/general principles and diagnostic approach. In: Murray JF, Nadel JA (ed) Textbook of respiratory medicine, 2nd edn. Saunders, Philadelphia, pp 963–976Google Scholar
  12. Hayden FG, Gwaltney, JM Jr (1994) Infectious diseases of the lungs/viral infections. In: Murray JF, Nadel JA (ed) Textbook of respiratory medicine, 2nd edn. Saunders, Philadelphia, pp 977–1035Google Scholar
  13. Höffken G, Lorenz J, Kern W et al. (2005) S3-Leitlinie zu ambulant erworbener Pneumonie und tiefen Atemwegsinfektionen. Pneumologie 59:612–664PubMedGoogle Scholar
  14. Hopwell PC, Bloom BR (1994) Infectious diseases of the lungs/tuberculosis and other mycobacterial diseases. In: Murray JF, Nadel JA (ed) Textbook of respiratory medicine, 2nd edn. Saunders, Philadelphia, pp 1094–1160Google Scholar
  15. Johnson CC, Finegold SM (1994) Infectious diseases of the lungs/pyogenic bacterial pneumonia, lung abscess, and empyema. In: Murray JF, Nadel JA (ed) Textbook of respiratory medicine, 2nd edn. Saunders, Philadelphia, pp 1036–1093Google Scholar
  16. Lode H, Schaberg T, Raffenberg M (1997) Therapie der nosokomialen Pneumonie. Dtsch Med Wochenschr 122:93–96PubMedGoogle Scholar
  17. Mandell LA, Wunderink RG, Anzueto A et al. (2007) Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 44: 27–72Google Scholar
  18. Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN (1996) Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 101:508–515PubMedGoogle Scholar
  19. Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P (1994) Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. (French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit). Chest 105: 1487–1495PubMedGoogle Scholar
  20. Pennington JE (1989) Community-acquired pneumonia and acute bronchitis. In: Pennington JE (ed) Respiratory infections: diagnosis and management, 2nd edn. Raven, New York, pp 159–170Google Scholar
  21. Pennington JE (1989) Hospital-acquired pneumonia. In: Pennington JE (ed) Respiratory infections: diagnosis and management, 2nd edn. Raven, New York, pp 171–186Google Scholar
  22. Pennington JE (1989) Opportunistic fungal pneumonias: aspergillus, mucor, candida, torulopsis. In: Pennington JE (ed) Respiratory infections: diagnosis and management, 2nd edn. Raven, New York, pp 443–456Google Scholar
  23. Petersen C, Mills J (1994) Infectious diseases of the lungs/parasitic infections. In: Murray JF, Nadel JA (ed) Textbook of respiratory medicine, 2nd edn. Saunders, Philadelphia, pp 1201–1244Google Scholar
  24. Riquelme R, Torres A, el-Ebiary M et al. (1996) Community-acquired pneumonia in the elderly. Am J Respir Crit Care Med 154:1450–1455PubMedGoogle Scholar
  25. Roig J, Domingo C, Morera J (1994) Legionaires disease. Chest 105:1817–1825PubMedGoogle Scholar
  26. Schaberg T, Dalhoff K, Lorenz J, Mauch H, Wilkens H, Witt C (1997) Deutsche Gesellschaft für Pneumologie: Empfehlungen zur Diagnostik der ambulant erworbenen Pneumonie. Pneumologie 51:69–77PubMedGoogle Scholar
  27. Vila-Corcoles A, Ochoa-Gondar O, Hospital I et al. (2006) Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population. The EVAN-65 study. Clin Infect Dis 43:860–868PubMedGoogle Scholar

Literatur

  1. American Thoracic Society (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156:S1–25Google Scholar
  2. Casanova JL, Abel L (2002) Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20: 581–620PubMedGoogle Scholar
  3. Corbett EL, Marston B et al. (2006) Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367(9514):926–37PubMedGoogle Scholar
  4. Cox H, Kebede Y et al. (2006) Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. PLoS Med 3(10):e384PubMedGoogle Scholar
  5. Daley CL, Griffith DE (2002) Pulmonary disease caused by rapidly growing mycobycteria. Clin Chest Med 23:623–32PubMedGoogle Scholar
  6. Diel R, Ernst M et al. (2006) Avoiding the effect of BCG-vaccination in detecting MTB infection with a blood test. Eur Respir J 28:16–23PubMedGoogle Scholar
  7. Dye C (2006) Global epidemiology of tuberculosis. Lancet 367(9514):938–40PubMedGoogle Scholar
  8. Ellis SM, Hansell DM (2002) Imaging of Non-tuberculous (Atypical) Mycobycterial Pulmonary Infection. Cin Radiol 57:661–9Google Scholar
  9. Ewer K, Deeks J et al. (2003) Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361(9364):1168–73PubMedGoogle Scholar
  10. Ferrara GM, Losi et al. (2006) Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367(9519):1328–34PubMedGoogle Scholar
  11. Field SK, Fisher D, Cowie RL (2004) Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 126:566–81PubMedGoogle Scholar
  12. Field SK, Cowie RL (2006) Lung disease due to more common nontuberculous mycobycteria. Chest 129:1653–72PubMedGoogle Scholar
  13. Garcia Garcia JM, Palacios Gutierrez JJ et al. (2005) Respiratory infections caused by environmental mycobacteria. Arch Bronconeumol 41(4):206–19PubMedGoogle Scholar
  14. Greinert U, Zabel P (2003) Tuberculosis-current therapeutic principles. Internist 44(11):1394–405PubMedGoogle Scholar
  15. Greinert U, Schlaak M, Rüsch, Gerdes S et al. (2000) Low in vitro production of interferon-gamma and tumor necrosis factor alpha in HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria. J Cin Immunol 20:445–52Google Scholar
  16. Hallstrand TS, Ochs HD, Zhu Q et al. (2004) Inhaled IFN-γ for persistent nontuberculous mycobacterial pulmonary disease due to functional INF-γ deficiency. Eur Respir J 24:367–70PubMedGoogle Scholar
  17. Henry MT, Inamdar L, O’Riordain et al. (2004) Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 23:741–6PubMedGoogle Scholar
  18. Jafari C, Ernst M et al. (2006) Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 174(9):1048–54PubMedGoogle Scholar
  19. Kim JS, Tanaka N, Newell JD et al. (2005) Nontuberculous mycobacterial infection: CT scan findings, genotype, and treatment responsiveness. Chest 128:3863–9PubMedGoogle Scholar
  20. Konietzko N (2000) Pulmonary Mycobacterium avium infections in no immunosuppressed patients: a new disease? Pneumologie 54:454–7PubMedGoogle Scholar
  21. Lange C, Schaaf B et al. (2004) HIV and lung. Pneumologie 58(6):416–27PubMedGoogle Scholar
  22. Lange C, Schaberg T et al. (2006) Current position regarding the diagnosis of tuberculosis. Dtsch Med Wochenschr 131(7):341–7PubMedGoogle Scholar
  23. Lange CG, Schieferstein C et al. (2007) Tuberculosis. HIV medicine 2007. www.hivmedicine.com 15:1-14Google Scholar
  24. Marras TK, Daley CL (2002) Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med.23:553–67PubMedGoogle Scholar
  25. Marras TK, Wallace jr. RJ, Koth LL et al. (2005) Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest 127:664–71PubMedGoogle Scholar
  26. Mukherjee JS, Rich ML, Socci AR et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004;363:474–81PubMedGoogle Scholar
  27. Olivier KN, Weber DJ, Wallace RJ jr et al. (2003) Nontuberculous Mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167:828–34PubMedGoogle Scholar
  28. Pai M, Riley LW et al. (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4(12):761–76PubMedGoogle Scholar
  29. Richeldi L (2006) An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 174(7):736–42PubMedGoogle Scholar
  30. Robert Koch Institut (2005) Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2003. Robert Koch Institut, BerlinGoogle Scholar
  31. Schaberg T, Forssbohm M et al. (2001) Guidelines for drug treatment of tuberculosis in adults and childhood. Pneumologie 55(11):494–511PubMedGoogle Scholar
  32. Schaberg T, Hauer B et al. (2004) Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany. Pneumologie 58(4):255–70PubMedGoogle Scholar
  33. Schaberg T, Hauer B et al. (2004) Recommendations for personal respiratory protection in tuberculosis. Pneumologie 58(2):92–102PubMedGoogle Scholar
  34. Sokal JE (1975) Editorial: Measurement of delayed skin-test responses. N Engl J Med 293(10):501–2PubMedGoogle Scholar
  35. Waller EA, Roy A, Brumble L et al. (2006) The expanding spectrum of Mycobacterium avium Complex-associated pulmonary disease. Chest 130:1234–41PubMedGoogle Scholar
  36. WHO (2005) Report: Global Tuberculosis Control — Surveillance, Planning, Financing. World Health Organization, GenfGoogle Scholar

Literatur

  1. ATS/ ERS (2002) International multidisciplinary consensus classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165:277–304Google Scholar
  2. ATS (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161:646–64Google Scholar
  3. Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification. Am J Respir Crit Care Med 157:1301–15PubMedGoogle Scholar
  4. King T, Schwarz MI (1999) Interstitial Lung Diseases. Decker, Hamilton, LondonGoogle Scholar
  5. Lange S (1986) Radiologische Diagnostik der Lungenerkrankungen. Thieme, StuttgartGoogle Scholar
  6. Shonfeld N, Frank W, Wenig S (1993) Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 60:38–44Google Scholar
  7. Sennekamp J, Müller-Wening D, Amthor M et al. (2006) Empfehlungen zur Diagnostik der exogen-allergischen Alveolitis. Allergologie 29:431–438Google Scholar
  8. Fichter J, Doberauer C, Seegenschmiedt H (2007) Langerhans-Zellhistiozytose des Erwachsenen — eine interdisziplinäre Herausforderung. Langerhans Cell Histiocytosis in Adults — an Interdisciplinary Challenge. Dtsch Arztebl 104:34–35Google Scholar

Literatur

  1. Asherson RA, Cervera R, Piette JC et al. (1998) Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine 77/3:195–207Google Scholar
  2. Brown KK. (2006) Pulmonary Vasculitis. Proc Am Thorac Soc 3:48–57.PubMedGoogle Scholar
  3. Cannon GW, Zimmermann GA (eds) (1990) The lung in rheumatic diseases. Dekker, New York, BaselGoogle Scholar
  4. Cheema GS, Quismorio FP (2000) Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulmon Med 6:424–429Google Scholar
  5. Collins CE, Quismorio FP Jr (2005) Pulmonary involvement in microscopic polyangiitis. Cur Opin Pulm Med 11:447–451Google Scholar
  6. Crausman RS, Achenbach GA, Pluss WT, O’Brien RF, Jennings CA (1995) Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol 22/3:554–556Google Scholar
  7. Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR (2001) Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiopgraphy, and pulmonary function tests. Thorax 56:622–627PubMedGoogle Scholar
  8. Dheda K, Lallo UG, Cassim B, Mody GM (2004) Experience with azathioprine in systemic sclerosis associated with interstitial lung disease. Clin Rheumatol 23:306–309PubMedGoogle Scholar
  9. Fauci AS, Barton H, Katz P, Wolff S (1983) Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76–85PubMedGoogle Scholar
  10. Fujisawa T, Suda T, Nakamura Y et al. (2005) Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol 32:58–64PubMedGoogle Scholar
  11. Frankel SK, Cosgrove GP, Fischer A, Meehan RT, Brown K. (2006) Update in the diagnosis and management of pulmonary vasculits. Chest: 452–465Google Scholar
  12. Hellmich B, Metzler C, Gross WL (2006) Churg-Strauss-Syndrom — Aktueller Stand der Diagnostik und Therapie. Dtsch Med Wochenschr 131:2270–2274PubMedGoogle Scholar
  13. Ito I, Nagia S, Kitaichi M et al (2005) Pulmonary manifestations of primary Sjögren’s syndrome. Am J Respir Crit Care Med 171: 632–638PubMedGoogle Scholar
  14. Jayne D, Rasmussen N, Andrassy K et al. (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36–44PubMedGoogle Scholar
  15. Jenette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl. J Med 337:1512–1523Google Scholar
  16. Jenette JC, Falk RJ, Andrassy K et al. (1994) Chapel Hill: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187–192Google Scholar
  17. Jennings CA, King TE Jr, Tuder R, Cherniack RM, Schwarz MI (1997) Diffuse alveolar hemorrhage with underlying isolated, pauciimune pulmonary capillaritis. Am J Respir Crit Care Med 155:1101–1109PubMedGoogle Scholar
  18. Lamprecht P, Gause A, Gross WL (1999) Cryoglobulinemic vasculitis. Arthritis Rheum 42(12):2507–2516PubMedGoogle Scholar
  19. Leavitt RY, Fauci AS, Bloch DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Wegeners granulomatosis. Arthritis Rheum 33:1101–1107PubMedGoogle Scholar
  20. Lee H-K, Kim DS, Yoo B et al. (2005) Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127:2019–2027PubMedGoogle Scholar
  21. Levy JB, Turner AN, Rees AJ, Pusey CD (2001) Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134:1033–1042PubMedGoogle Scholar
  22. Lynch JP, Fishbein MC, White ES (2007) Pulmonary Vasculitis. In: Costabel U, du Bois RM, Egan JJ (eds) Diffuse parenchymal lung disease. Karger, Basel, S. 196–211Google Scholar
  23. Mahadeva R, Walsh G, Flower CDR, Shneerson JM (2000) Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 15:41–48PubMedGoogle Scholar
  24. Nadrous HF, Yu AC, Specks U, Ryu JH (2004) Pulmonary involvement in Henoch-Schonlein purpura. Mayo Clin Proc 79:1151–1157PubMedGoogle Scholar
  25. Nugent AM, Elliott H, McGuigan JA, Varghese G (1996) Pulmonary amyloidosis: treatment with laser therapy and systemic steroids. Repiration Medicine 90:433–435Google Scholar
  26. Olson AL, Schwarz MI (2007) Diffuse Alveolar Hemorrhage. In: Costabel U, du Bois RM, Egan JJ (eds) Diffuse parenchymal lung disease. Karger, Basel, S. 250–263Google Scholar
  27. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH (2006) Interstitial lung disease in primary Sjögren syndrome. Chest 130:1489–1495PubMedGoogle Scholar
  28. Park I-N, Kim SD, Shim TS et al. (2007) Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132:214–220PubMedGoogle Scholar
  29. Park JH, Kim DS, Park I-N et al. (2007) Prognosis of fibrotic interstitial pneumonia. Idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 175:705–711PubMedGoogle Scholar
  30. Patatanian E, Thompson DF (2002) A review of methotrexate-induced accelerated nodulosis. Pharmacotherapy 22:1157–1162PubMedGoogle Scholar
  31. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary stemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–99PubMedGoogle Scholar
  32. Röcken C, Ernst J, Hund E et al. (2006) Interdisziplinäre Leitlinien zur Diagnostik und Therapie der extrazerebralen Amyloidosen. Med Klin 101:825–82Google Scholar
  33. Röther E, Kempis J von, Peter HH (1999) Kriterien zur Diagnose oder Klassifikation rheumatischer Erkrankungen, 3. Aufl. Rheumazentrum Südbaden der Medizinischen Universitätsklinik FreiburgGoogle Scholar
  34. Sanchez O, Sitbon O, Jais X, Simonneau G, Humbert M (2006) Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 130:182–189PubMedGoogle Scholar
  35. Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis 66:940–944PubMedGoogle Scholar
  36. Tansey D, Wells AU, Colby TV et al. (2004) Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 44:585–596PubMedGoogle Scholar
  37. Tashkin DP, Elashoff R, Clements PJ et al. (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655–2666PubMedGoogle Scholar
  38. Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behcet disease: a cumulative analysis. Chest 127:2243–2253PubMedGoogle Scholar
  39. Vanoli M, Daina E, Salvarani C et al. (2005) Takayasu’s arteritis: a study of 104 Italian patients. Arthritis Rheum 53:100–107PubMedGoogle Scholar
  40. Verleden GM, Demedts MG, Westhovens R, Thomeer M (eds) (2005) Pulmonary manifestations of systemic diseases. Eur Respir Monograph 34, Volume 10, European Respirator Society Journals, SheffieldGoogle Scholar
  41. Willms H, Gutjahr K, Juergens UR et al. (2007) Die idiopathische pulmonale Hämosiderose. Med Klin 102:445–50Google Scholar
  42. Yousem SA, Colby TV, Carrington CB (1985) Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 131:770–777PubMedGoogle Scholar

Literatur

  1. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A (1999) Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 160(5 Pt 1):1668–72PubMedGoogle Scholar
  2. Baughman RP, Drent M, Kavuru M et al. (2006) Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795–802PubMedGoogle Scholar
  3. Becker ML, Rose CD (2005) Blau syndrome and related genetic disorders causing childhood arthritis. Curr Rheumatol Rep 7(6):427–33PubMedGoogle Scholar
  4. Biller H, Zissel G, Ruprecht B, Nauck M, Busse Grawitz A, Müller-Quernheim J (2006) Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur Respir J 28(6):1085–90PubMedGoogle Scholar
  5. Bohle W, Schaefer HE (1994) Predominant myocardial sarcoidosis. Pathol Res Pract 190(2):212–7; discussion 217–9PubMedGoogle Scholar
  6. Carlesimo M, Giustini S, Rossi A, Bonaccorsi P, Calvieri S (1995) Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 32(5 Pt 2):866–9PubMedGoogle Scholar
  7. Gibson G, Prescott R, Muers M et al. (1996) British Thoracic Society sarcoidosis study: Effects of long term corticosteroid treatment. Thorax 51:238–47PubMedGoogle Scholar
  8. Hunninghake GW, Gilbert S, Pueringer R et al. (1994) Outcome of the treatment of sarcoidosis. Am J Respir Crit Care Med 149:893–8PubMedGoogle Scholar
  9. Mende D, Suchenwirth R (1990) Neurosarkoidose, vergleichende Analyse des klinischen Profils anhand von 537 Beobachtungen aus der Weltliteratur bis 1963 und von 1976–1988. Fortschr Neurol Psychiat 58:7–18PubMedGoogle Scholar
  10. Müller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U (1998) Treatment of sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J 157:A31Google Scholar
  11. Müller-Quernheim J (1998) Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 12(3):716–38PubMedGoogle Scholar
  12. Müller-Quernheim J, Gaede KI, Prasse A, Zissel G (2007) Chronische Berylliose. Pneumologie 61:109–16PubMedGoogle Scholar
  13. Seersholm N, Vestbo J, Viskum K (1997) Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax 52(10):892–4PubMedGoogle Scholar
  14. Shammas RL, Movahed A (1993) Sarcoidosis of the heart. Clin Cardiol 16:462–72PubMedGoogle Scholar
  15. Suzuki T, Kanda T, Kubota S, Imai S, Murata K (1994) Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 106:1021–4PubMedGoogle Scholar
  16. Viskum K, Vestbo J (1993) Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 6:349–53PubMedGoogle Scholar
  17. Zabel P, Entzian P, Dalhoff K, Schlaak M (1997) Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med 155:1665–9PubMedGoogle Scholar
  18. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Müller-Quernheim J (1997) Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 156:1586–92PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2008

Authors and Affiliations

  • U. Costabel
    • 1
  • U. Greinert
    • 2
  • A. Günther
    • 3
  • F. Grimminger
    • 3
  • C. Lange
    • 2
  • J. Lohmeyer
    • 4
  • J. Müller-Quernheim
    • 5
  • A. Prasse
    • 6
  • E. W. Russi
    • 7
  • W. Seeger
    • 8
  • B. Temmesfeld-Wollbrück
    • 9
  • H. D. Walmrath
    • 10
  • P. Zabel
    • 2
  1. 1.RuhrlandklinikAbteilung Pneumologie/AllergologieEssen
  2. 2.Medizinische Klinik BorstelBorstel
  3. 3.Justus-Liebig-Universität GießenMedizinische Klinik IIGießen
  4. 4.Abt. für Infektiologie Med. Klinik IIUniversitäts Klinik GießenGießen
  5. 5.Medizinische Klinik Abteilung PneumologieUniversitätsklinikum FreiburgFreiburg
  6. 6.Abteilung für PneumologieUniversitätsklinikum FreiburgFreiburg
  7. 7.Abteilung für PneumologieUniversitätsspital ZürichZürichSchweiz
  8. 8.Medizinische Klinik IIJustus-Liebig-Universität GießenGießen
  9. 9.Medizinische Klinik m. S. Infektiologie und Pneumologie Campus Virchow KlinikumCharité-Universitätsmedizin BerlinBerlin
  10. 10.Medizinische Klinik IIUniversitätsklinikum GießenGießen

Personalised recommendations